{
    "clinical_study": {
        "@rank": "168214", 
        "arm_group": [
            {
                "arm_group_label": "Laser", 
                "arm_group_type": "Experimental", 
                "description": "A laser will be used to clean out the area around the diseased implant to try to regain bone."
            }, 
            {
                "arm_group_label": "Mechanical", 
                "arm_group_type": "Active Comparator", 
                "description": "Mechanical debridement will be used to clean out the area around the diseased implant to try to regain bone."
            }
        ], 
        "brief_summary": {
            "textblock": "The primary objective of this study is to compare the clinical outcomes of using Er: YAG\n      laser along with bone graft and barrier membrane  to conventional mechanical debridement\n      also with bone graft and barrier membrane in the treatment of peri-implantitis infections."
        }, 
        "brief_title": "Laser Therapy Treatment of Peri-implantitis.", 
        "condition": "Peri-implantitis", 
        "condition_browse": {
            "mesh_term": "Peri-Implantitis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients, aged 18 - 85 years\n\n          -  Physical status according to the American Society of Anesthesiologists (ASA) I or II,\n             which includes patients who are systemically healthy or suffer under mild to\n             moderate, but well controlled systemic diseases.\n\n          -  Patients having a minimum of 1 dental implant with peri-implantitis.\n\n          -  The dental implant with peri-implantitis has \u2265 3 threads exposed or pocket probing\n             depth (PPD) \u2265 5mm, with bleeding on probing (BOP) and/or suppuration (pus).\n\n          -  The implants are in function for at least 6 months\n\n          -  No uncontrolled systemic disease or condition known to alter bone metabolism, like\n             Osteoporosis, Osteopenia, Hyperparathyroidism, Paget's disease.\n\n          -  Only rough surface implant will be included in this study\n\n        Exclusion Criteria:\n\n          -  Long-term use of antibiotics > 2 weeks in the past two months\n\n          -  No peri-implantitis treatment in the last 2 months\n\n          -  Patients taking medications known to modify bone metabolism (such as bisphosphonates,\n             corticosteroids, Hormone replacement therapy for menopausal women, Parathyroid\n             hormone, Denosumab, strontium ranelate).\n\n          -  Pregnant females or those planning to become pregnant.\n\n          -  Patients with a history of medically diagnosed oral cancer, bisphosphonate usage,\n             Sepsis or those having adverse outcomes to oral procedures in the past, will be\n             excluded\n\n          -  Mobility of dental implants\n\n          -  History of alcoholism or drug abuse\n\n          -  Current smokers or quit smoking less than 6 months\n\n          -  Diseases of the immune system or any medical condition that may influence the outcome\n             (uncontrolled diabetes (HbA1c >7)\n\n          -  Patients with allergies known to affect one or more of the treatment provided in this\n             study\n\n          -  Polish surface implants\n\n          -  Implants with trabecular surface"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "32", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01972399", 
            "org_study_id": "HUM00077816"
        }, 
        "intervention": [
            {
                "arm_group_label": "Laser", 
                "description": "This is a surgery that the patient will undergo and the laser will be used to clean the surface of the implant.", 
                "intervention_name": "Laser", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Mechanical", 
                "description": "This is a surgery that the patient will undergo to have the surface of the implant cleaned using hand instruments.", 
                "intervention_name": "Mechanical debridement", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "October 24, 2013", 
        "location": {
            "contact": {
                "email": "acransto@umich.edu", 
                "last_name": "Cranston"
            }, 
            "facility": {
                "address": {
                    "city": "Ann Arbor", 
                    "country": "United States", 
                    "state": "Michigan", 
                    "zip": "48109"
                }, 
                "name": "University of Michigan School of Dentistry"
            }, 
            "investigator": {
                "last_name": "Fernando Suarez, DDS", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Influence of Laser Therapy Upon Surgical Treatment of Peri-implantitis Lesions.", 
        "overall_contact": {
            "email": "acransto@umich.edu", 
            "last_name": "Andrea L Cranston, BSDH", 
            "phone": "734-763-3346"
        }, 
        "overall_contact_backup": {
            "email": "fsuarez@umich.edu", 
            "last_name": "Fernando Suarez, DDS", 
            "phone": "734-763-3346"
        }, 
        "overall_official": {
            "affiliation": "University of Michigan", 
            "last_name": "Fernando Suarez, DDS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Perio Probing Depth", 
            "safety_issue": "No", 
            "time_frame": "Change in probing depth from beginning of study to 6 months after intervention"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01972399"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Michigan", 
            "investigator_full_name": "Dr Hom-Lay Wang", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Bleeding on Probing", 
            "safety_issue": "No", 
            "time_frame": "Change in bleeding on probing from beginning of study to 6 months after intervention"
        }, 
        "source": "University of Michigan", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Michigan", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}